The history of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of knock-off medications, significantly eroding its dominance. While specific pharmaceutical companies may seek to capitalize on related